HOXA7 and colorectal carcinoma: Our work indicated that HOXA7 is a potential prognostic biomarker for KRAS mutant CRC, and targeting the oncogenic loop may provide a promising therapeutic strategy for HOXA7-mediated KRAS mutant CRC metastasis.